MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ALGS made $741,000 in revenue. -$31,502,000 in net income. Net profit margin of -4251.28%.

Income Overview

Revenue
$741,000
Net Income
-$31,502,000
Net Profit Margin
-4251.28%
EPS
-$3.04
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenue from customers
741,000 965,000 -105,000
Research and development
23,937,000 13,976,000 14,502,000 17,831,666.667
General and administrative
5,165,000 5,556,000 5,052,000 6,068,000
Total operating expenses
29,102,000 19,532,000 19,554,000 23,899,666.667
Revenue from customers
--311,000 787,000
Loss from operations
-28,361,000 -18,567,000 -19,243,000 -23,007,666.667
Interest and other income, net
1,085,000 1,207,000 880,000 1,147,666.667
Change in fair value of 2023 common warrants
4,205,000 -1,682,000 -61,494,000 7,688,666.667
Loss before income tax
-31,481,000 -15,678,000 43,131,000 -37,237,333.333
Income tax provision
56,000 185,000 43,000 80,000
Net loss
-31,537,000 -15,863,000 43,088,000 -37,317,333.333
Unrealized gain on available-for-sale securities
35,000 -27,000 -4,000 -24,666.667
Unrealized (loss) gain on pension plans
---17,166.667
Other comprehensive gain
35,000 -27,000 -4,000 -59,000
Comprehensive loss
-31,502,000 -15,890,000 43,084,000 -37,376,333.333
Earnings per share, basic, total
-3.04 -1.53 5.12 -5.957
Earnings per share, diluted, total
-3.04 -1.53 -2.11 -5.957
Weighted average number of shares outstanding, basic, total
10,369,535 10,351,120 8,408,481 -2,559.667
Weighted average shares of common stock, diluted
10,369,535 10,351,120 8,709,693 -2,559.667
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized gain onavailable-for-sale securities$35,000 Comprehensive loss-$31,502,000 Other comprehensivegain$35,000 Net loss-$31,537,000 Income tax provision$56,000 Loss before incometax-$31,481,000 Interest and otherincome, net$1,085,000 Change in fair value of2023 common warrants$4,205,000 Loss from operations-$28,361,000 Revenue from customers$741,000 Total operatingexpenses$29,102,000 General andadministrative$5,165,000 Research and development$23,937,000

Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics, Inc. (ALGS)